カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

バイオシミラーモノクローナル抗体の世界市場2022：インフリキシマブ、リツキシマブ、トラスツズマブ、アダリムマブ、その他

■ 英語タイトル：Global Biosimilar Monoclonal Antibodies Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22DC3758）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22DC3758
■ 発行日：2023年1月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：92
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥522,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥783,000見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,044,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[バイオシミラーモノクローナル抗体の世界市場2022：インフリキシマブ、リツキシマブ、トラスツズマブ、アダリムマブ、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

世界のバイオシミラーモノクローナル抗体市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界のバイオシミラーモノクローナル抗体の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

バイオシミラーモノクローナル抗体市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・インフリキシマブ、リツキシマブ、トラスツズマブ、アダリムマブ、その他

アプリケーション別セグメントは次のように区分されます。
・腫瘍、自己免疫疾患、その他

世界のバイオシミラーモノクローナル抗体市場の主要な市場プレーヤーは以下のとおりです。
・Celltrion、Pfizer (Hospira)、3SBIO、Novartis (Sandoz)、Dr Reddy’s、Celgen Biopharma、Cadila Healthcare、Hisun Pharma、Torrent Pharmaceuticals

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、バイオシミラーモノクローナル抗体製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なバイオシミラーモノクローナル抗体メーカーの企業概要、2019年～2022年までのバイオシミラーモノクローナル抗体の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なバイオシミラーモノクローナル抗体メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別バイオシミラーモノクローナル抗体の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのバイオシミラーモノクローナル抗体の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのバイオシミラーモノクローナル抗体市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびバイオシミラーモノクローナル抗体の産業チェーンを掲載しています。
・第13、14、15章では、バイオシミラーモノクローナル抗体の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– バイオシミラーモノクローナル抗体の概要
– 種類別分析（2017年vs2021年vs2028年）：インフリキシマブ、リツキシマブ、トラスツズマブ、アダリムマブ、その他
– 用途別分析（2017年vs2021年vs2028年）：腫瘍、自己免疫疾患、その他
– 世界のバイオシミラーモノクローナル抗体市場規模・予測
– 世界のバイオシミラーモノクローナル抗体生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Celltrion、Pfizer (Hospira)、3SBIO、Novartis (Sandoz)、Dr Reddy’s、Celgen Biopharma、Cadila Healthcare、Hisun Pharma、Torrent Pharmaceuticals
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：インフリキシマブ、リツキシマブ、トラスツズマブ、アダリムマブ、その他
・用途別分析2017年-2028年：腫瘍、自己免疫疾患、その他
・バイオシミラーモノクローナル抗体の北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・バイオシミラーモノクローナル抗体のヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・バイオシミラーモノクローナル抗体のアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・バイオシミラーモノクローナル抗体の南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・バイオシミラーモノクローナル抗体の中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Biosimilar Monoclonal Antibodies Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biosimilar Monoclonal Antibodies Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Infliximab
1.2.3 Rituximab
1.2.4 Trastuzumab
1.2.5 Adalimumab
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Biosimilar Monoclonal Antibodies Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Autoimmune Disease
1.3.4 Other
1.4 Global Biosimilar Monoclonal Antibodies Market Size & Forecast
1.4.1 Global Biosimilar Monoclonal Antibodies Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Biosimilar Monoclonal Antibodies Sales in Volume (2017-2028)
1.4.3 Global Biosimilar Monoclonal Antibodies Price (2017-2028)
1.5 Global Biosimilar Monoclonal Antibodies Production Capacity Analysis
1.5.1 Global Biosimilar Monoclonal Antibodies Total Production Capacity (2017-2028)
1.5.2 Global Biosimilar Monoclonal Antibodies Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Biosimilar Monoclonal Antibodies Market Drivers
1.6.2 Biosimilar Monoclonal Antibodies Market Restraints
1.6.3 Biosimilar Monoclonal Antibodies Trends Analysis
2 Manufacturers Profiles
2.1 Celltrion
2.1.1 Celltrion Details
2.1.2 Celltrion Major Business
2.1.3 Celltrion Biosimilar Monoclonal Antibodies Product and Services
2.1.4 Celltrion Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer (Hospira)
2.2.1 Pfizer (Hospira) Details
2.2.2 Pfizer (Hospira) Major Business
2.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product and Services
2.2.4 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 3SBIO
2.3.1 3SBIO Details
2.3.2 3SBIO Major Business
2.3.3 3SBIO Biosimilar Monoclonal Antibodies Product and Services
2.3.4 3SBIO Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Novartis (Sandoz)
2.4.1 Novartis (Sandoz) Details
2.4.2 Novartis (Sandoz) Major Business
2.4.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product and Services
2.4.4 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Dr Reddy’s
2.5.1 Dr Reddy’s Details
2.5.2 Dr Reddy’s Major Business
2.5.3 Dr Reddy’s Biosimilar Monoclonal Antibodies Product and Services
2.5.4 Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Celgen Biopharma
2.6.1 Celgen Biopharma Details
2.6.2 Celgen Biopharma Major Business
2.6.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Product and Services
2.6.4 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Cadila Healthcare
2.7.1 Cadila Healthcare Details
2.7.2 Cadila Healthcare Major Business
2.7.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Product and Services
2.7.4 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Hisun Pharma
2.8.1 Hisun Pharma Details
2.8.2 Hisun Pharma Major Business
2.8.3 Hisun Pharma Biosimilar Monoclonal Antibodies Product and Services
2.8.4 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Torrent Pharmaceuticals
2.9.1 Torrent Pharmaceuticals Details
2.9.2 Torrent Pharmaceuticals Major Business
2.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product and Services
2.9.4 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Biosimilar Monoclonal Antibodies Breakdown Data by Manufacturer
3.1 Global Biosimilar Monoclonal Antibodies Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Biosimilar Monoclonal Antibodies Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Biosimilar Monoclonal Antibodies
3.4 Market Concentration Rate
3.4.1 Top 3 Biosimilar Monoclonal Antibodies Manufacturer Market Share in 2021
3.4.2 Top 6 Biosimilar Monoclonal Antibodies Manufacturer Market Share in 2021
3.5 Global Biosimilar Monoclonal Antibodies Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Biosimilar Monoclonal Antibodies Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Biosimilar Monoclonal Antibodies Market Size by Region
4.1.1 Global Biosimilar Monoclonal Antibodies Sales in Volume by Region (2017-2028)
4.1.2 Global Biosimilar Monoclonal Antibodies Revenue by Region (2017-2028)
4.2 North America Biosimilar Monoclonal Antibodies Revenue (2017-2028)
4.3 Europe Biosimilar Monoclonal Antibodies Revenue (2017-2028)
4.4 Asia-Pacific Biosimilar Monoclonal Antibodies Revenue (2017-2028)
4.5 South America Biosimilar Monoclonal Antibodies Revenue (2017-2028)
4.6 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Biosimilar Monoclonal Antibodies Sales in Volume by Type (2017-2028)
5.2 Global Biosimilar Monoclonal Antibodies Revenue by Type (2017-2028)
5.3 Global Biosimilar Monoclonal Antibodies Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Biosimilar Monoclonal Antibodies Sales in Volume by Application (2017-2028)
6.2 Global Biosimilar Monoclonal Antibodies Revenue by Application (2017-2028)
6.3 Global Biosimilar Monoclonal Antibodies Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Biosimilar Monoclonal Antibodies Sales by Type (2017-2028)
7.2 North America Biosimilar Monoclonal Antibodies Sales by Application (2017-2028)
7.3 North America Biosimilar Monoclonal Antibodies Market Size by Country
7.3.1 North America Biosimilar Monoclonal Antibodies Sales in Volume by Country (2017-2028)
7.3.2 North America Biosimilar Monoclonal Antibodies Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Biosimilar Monoclonal Antibodies Sales by Type (2017-2028)
8.2 Europe Biosimilar Monoclonal Antibodies Sales by Application (2017-2028)
8.3 Europe Biosimilar Monoclonal Antibodies Market Size by Country
8.3.1 Europe Biosimilar Monoclonal Antibodies Sales in Volume by Country (2017-2028)
8.3.2 Europe Biosimilar Monoclonal Antibodies Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Type (2017-2028)
9.2 Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Application (2017-2028)
9.3 Asia-Pacific Biosimilar Monoclonal Antibodies Market Size by Region
9.3.1 Asia-Pacific Biosimilar Monoclonal Antibodies Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Biosimilar Monoclonal Antibodies Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Biosimilar Monoclonal Antibodies Sales by Type (2017-2028)
10.2 South America Biosimilar Monoclonal Antibodies Sales by Application (2017-2028)
10.3 South America Biosimilar Monoclonal Antibodies Market Size by Country
10.3.1 South America Biosimilar Monoclonal Antibodies Sales in Volume by Country (2017-2028)
10.3.2 South America Biosimilar Monoclonal Antibodies Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Biosimilar Monoclonal Antibodies Sales by Type (2017-2028)
11.2 Middle East & Africa Biosimilar Monoclonal Antibodies Sales by Application (2017-2028)
11.3 Middle East & Africa Biosimilar Monoclonal Antibodies Market Size by Country
11.3.1 Middle East & Africa Biosimilar Monoclonal Antibodies Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Biosimilar Monoclonal Antibodies Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Biosimilar Monoclonal Antibodies and Key Manufacturers
12.2 Manufacturing Costs Percentage of Biosimilar Monoclonal Antibodies
12.3 Biosimilar Monoclonal Antibodies Production Process
12.4 Biosimilar Monoclonal Antibodies Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Biosimilar Monoclonal Antibodies Typical Distributors
13.3 Biosimilar Monoclonal Antibodies Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Biosimilar Monoclonal Antibodies Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Biosimilar Monoclonal Antibodies Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Celltrion Basic Information, Manufacturing Base and Competitors
Table 4. Celltrion Major Business
Table 5. Celltrion Biosimilar Monoclonal Antibodies Product and Services
Table 6. Celltrion Biosimilar Monoclonal Antibodies Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer (Hospira) Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer (Hospira) Major Business
Table 9. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product and Services
Table 10. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. 3SBIO Basic Information, Manufacturing Base and Competitors
Table 12. 3SBIO Major Business
Table 13. 3SBIO Biosimilar Monoclonal Antibodies Product and Services
Table 14. 3SBIO Biosimilar Monoclonal Antibodies Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Novartis (Sandoz) Basic Information, Manufacturing Base and Competitors
Table 16. Novartis (Sandoz) Major Business
Table 17. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product and Services
Table 18. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Dr Reddy’s Basic Information, Manufacturing Base and Competitors
Table 20. Dr Reddy’s Major Business
Table 21. Dr Reddy’s Biosimilar Monoclonal Antibodies Product and Services
Table 22. Dr Reddy’s Biosimilar Monoclonal Antibodies Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Celgen Biopharma Basic Information, Manufacturing Base and Competitors
Table 24. Celgen Biopharma Major Business
Table 25. Celgen Biopharma Biosimilar Monoclonal Antibodies Product and Services
Table 26. Celgen Biopharma Biosimilar Monoclonal Antibodies Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Cadila Healthcare Basic Information, Manufacturing Base and Competitors
Table 28. Cadila Healthcare Major Business
Table 29. Cadila Healthcare Biosimilar Monoclonal Antibodies Product and Services
Table 30. Cadila Healthcare Biosimilar Monoclonal Antibodies Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Hisun Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Hisun Pharma Major Business
Table 33. Hisun Pharma Biosimilar Monoclonal Antibodies Product and Services
Table 34. Hisun Pharma Biosimilar Monoclonal Antibodies Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Torrent Pharmaceuticals Major Business
Table 37. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product and Services
Table 38. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Biosimilar Monoclonal Antibodies Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Biosimilar Monoclonal Antibodies Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Biosimilar Monoclonal Antibodies, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Biosimilar Monoclonal Antibodies Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Biosimilar Monoclonal Antibodies Production Site of Key Manufacturer
Table 44. Biosimilar Monoclonal Antibodies New Entrant and Capacity Expansion Plans
Table 45. Biosimilar Monoclonal Antibodies Mergers & Acquisitions in the Past Five Years
Table 46. Global Biosimilar Monoclonal Antibodies Sales by Region (2017-2022) & (K Units)
Table 47. Global Biosimilar Monoclonal Antibodies Sales by Region (2023-2028) & (K Units)
Table 48. Global Biosimilar Monoclonal Antibodies Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Biosimilar Monoclonal Antibodies Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Biosimilar Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
Table 51. Global Biosimilar Monoclonal Antibodies Sales by Type (2023-2028) & (K Units)
Table 52. Global Biosimilar Monoclonal Antibodies Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Biosimilar Monoclonal Antibodies Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Biosimilar Monoclonal Antibodies Price by Type (2017-2022) & (USD/Unit)
Table 55. Global Biosimilar Monoclonal Antibodies Price by Type (2023-2028) & (USD/Unit)
Table 56. Global Biosimilar Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
Table 57. Global Biosimilar Monoclonal Antibodies Sales by Application (2023-2028) & (K Units)
Table 58. Global Biosimilar Monoclonal Antibodies Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Biosimilar Monoclonal Antibodies Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Biosimilar Monoclonal Antibodies Price by Application (2017-2022) & (USD/Unit)
Table 61. Global Biosimilar Monoclonal Antibodies Price by Application (2023-2028) & (USD/Unit)
Table 62. North America Biosimilar Monoclonal Antibodies Sales by Country (2017-2022) & (K Units)
Table 63. North America Biosimilar Monoclonal Antibodies Sales by Country (2023-2028) & (K Units)
Table 64. North America Biosimilar Monoclonal Antibodies Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Biosimilar Monoclonal Antibodies Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Biosimilar Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
Table 67. North America Biosimilar Monoclonal Antibodies Sales by Type (2023-2028) & (K Units)
Table 68. North America Biosimilar Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
Table 69. North America Biosimilar Monoclonal Antibodies Sales by Application (2023-2028) & (K Units)
Table 70. Europe Biosimilar Monoclonal Antibodies Sales by Country (2017-2022) & (K Units)
Table 71. Europe Biosimilar Monoclonal Antibodies Sales by Country (2023-2028) & (K Units)
Table 72. Europe Biosimilar Monoclonal Antibodies Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Biosimilar Monoclonal Antibodies Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Biosimilar Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
Table 75. Europe Biosimilar Monoclonal Antibodies Sales by Type (2023-2028) & (K Units)
Table 76. Europe Biosimilar Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
Table 77. Europe Biosimilar Monoclonal Antibodies Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Biosimilar Monoclonal Antibodies Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Biosimilar Monoclonal Antibodies Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Application (2023-2028) & (K Units)
Table 86. South America Biosimilar Monoclonal Antibodies Sales by Country (2017-2022) & (K Units)
Table 87. South America Biosimilar Monoclonal Antibodies Sales by Country (2023-2028) & (K Units)
Table 88. South America Biosimilar Monoclonal Antibodies Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Biosimilar Monoclonal Antibodies Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Biosimilar Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
Table 91. South America Biosimilar Monoclonal Antibodies Sales by Type (2023-2028) & (K Units)
Table 92. South America Biosimilar Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
Table 93. South America Biosimilar Monoclonal Antibodies Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Biosimilar Monoclonal Antibodies Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Biosimilar Monoclonal Antibodies Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Biosimilar Monoclonal Antibodies Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Biosimilar Monoclonal Antibodies Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Biosimilar Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Biosimilar Monoclonal Antibodies Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Biosimilar Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Biosimilar Monoclonal Antibodies Sales by Application (2023-2028) & (K Units)
Table 102. Biosimilar Monoclonal Antibodies Raw Material
Table 103. Key Manufacturers of Biosimilar Monoclonal Antibodies Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Biosimilar Monoclonal Antibodies Typical Distributors
Table 107. Biosimilar Monoclonal Antibodies Typical Customers
List of Figures
Figure 1. Biosimilar Monoclonal Antibodies Picture
Figure 2. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type in 2021
Figure 3. Infliximab
Figure 4. Rituximab
Figure 5. Trastuzumab
Figure 6. Adalimumab
Figure 7. Other
Figure 8. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Application in 2021
Figure 9. Oncology
Figure 10. Autoimmune Disease
Figure 11. Other
Figure 12. Global Biosimilar Monoclonal Antibodies Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Biosimilar Monoclonal Antibodies Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Biosimilar Monoclonal Antibodies Sales (2017-2028) & (K Units)
Figure 15. Global Biosimilar Monoclonal Antibodies Price (2017-2028) & (USD/Unit)
Figure 16. Global Biosimilar Monoclonal Antibodies Production Capacity (2017-2028) & (K Units)
Figure 17. Global Biosimilar Monoclonal Antibodies Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Biosimilar Monoclonal Antibodies Market Drivers
Figure 19. Biosimilar Monoclonal Antibodies Market Restraints
Figure 20. Biosimilar Monoclonal Antibodies Market Trends
Figure 21. Global Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturer in 2021
Figure 22. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Manufacturer in 2021
Figure 23. Biosimilar Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Biosimilar Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Biosimilar Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2017-2028)
Figure 27. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2017-2028)
Figure 28. North America Biosimilar Monoclonal Antibodies Revenue (2017-2028) & (USD Million)
Figure 29. Europe Biosimilar Monoclonal Antibodies Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Biosimilar Monoclonal Antibodies Revenue (2017-2028) & (USD Million)
Figure 31. South America Biosimilar Monoclonal Antibodies Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Biosimilar Monoclonal Antibodies Revenue (2017-2028) & (USD Million)
Figure 33. Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 34. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
Figure 35. Global Biosimilar Monoclonal Antibodies Price by Type (2017-2028) & (USD/Unit)
Figure 36. Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 37. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Application (2017-2028)
Figure 38. Global Biosimilar Monoclonal Antibodies Price by Application (2017-2028) & (USD/Unit)
Figure 39. North America Biosimilar Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 40. North America Biosimilar Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 41. North America Biosimilar Monoclonal Antibodies Sales Market Share by Country (2017-2028)
Figure 42. North America Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2017-2028)
Figure 43. United States Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 47. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 48. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Country (2017-2028)
Figure 49. Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2017-2028)
Figure 50. Germany Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2017-2028)
Figure 59. China Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Biosimilar Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 66. South America Biosimilar Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 67. South America Biosimilar Monoclonal Antibodies Sales Market Share by Country (2017-2028)
Figure 68. South America Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Biosimilar Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Biosimilar Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Biosimilar Monoclonal Antibodies Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Biosimilar Monoclonal Antibodies in 2021
Figure 80. Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
Figure 81. Biosimilar Monoclonal Antibodies Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のレミケード（インフリキシマブ）モノクローナル抗体市場2023年：企業・地域・タイプ・用途別分析
  • 世界のリツキサン（リツキシマブ）モノクローナル抗体市場2023年：企業・地域・タイプ・用途別分析
  • レミケード（インフリキシマブ） 薬の世界市場2022：ブランド医薬品、ジェネリック医薬品
  • リツキサン（リツキシマブ）医薬品の世界市場2022：500mg、100mg
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22DC3758 )"バイオシミラーモノクローナル抗体の世界市場2022：インフリキシマブ、リツキシマブ、トラスツズマブ、アダリムマブ、その他" (英文：Global Biosimilar Monoclonal Antibodies Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。